Email Updates

Search form

You are here

A13-128

Status
Completed
Phase
I
Principal Investigator(s)
Jill Schwartz & Chris Mauck
Objective

To evaluate the:

  • safety of the TFV/LNG, and TFV-only intravaginal rings
  • pharmacokinetics of TFV and lNG
  • acceptability of intravaginal rings
Prevention Option(s)
Microbicides
Study Design
Controlled
Randomized
Double-blind
Arms and Assigned Interventions
Mode of Delivery
Ring
Products
TFV ring
ARMs
Experimental
Mode of Delivery
Ring
Products
TFV/LNG ring
ARMs
Experimental
Description
Placebo ring.
Mode of Delivery
Ring
ARMs
Placebo Comparator
Trial Sponsors
CONRAD
November 2014
November 2015
Enrollment
100
18
Years
45
Years
Population
Women
Sites

Eastern Virginia Medical School

Norfolk, Virginia
United States of America

Profamilia

Santo Domingo
Dominican Republic